These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7829156)

  • 1. Copper levels & reactive oxygen species in uterine flushings in copper intrauterine contraceptive device users.
    Gupta I; Kaushalya S; Gupta KR; Mahajan U; Prasad R; Ganguly NK
    Indian J Med Res; 1994 Nov; 100():225-7. PubMed ID: 7829156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active oxygen species in copper intrauterine device users.
    Amla S; Gupta I; Kausalya S; Ganguly NK
    Contraception; 1993 Aug; 48(2):150-6. PubMed ID: 8403911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper levels in users of multiload intra-uterine contraceptive devices.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1989 Dec; 18(4):295-9. PubMed ID: 2558561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the delta copper T and the copper T 200 in Bologna, Italy.
    Melega C; Biscontin S; Canedi L; Marchesini FP; Tirelli S; Bartolotti T; Flamigni C
    Acta Eur Fertil; 1986; 17(1):39-41. PubMed ID: 3727892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of the progesterone T intrauterine device].
    Pizarro Orchard E; Gómez Rogers C
    Rev Chil Obstet Ginecol; 1980; 45(2):87-98. PubMed ID: 6765370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of levonorgestrel and copper releasing intrauterine contraceptive device on body iron stores and menstrual bleeding patterns: experience on Indian women.
    Rana M; Saxena P; Firdous N
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):230-4. PubMed ID: 22428475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital mycoplasma in intrauterine contraceptive device users.
    Gupta I; Sharma S; Ganguli NK; Devi PK
    Indian J Pathol Microbiol; 1979 Jul; 22(3):235-8. PubMed ID: 544494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive molecules and microorganisms and copper intrauterine devices.
    Navada M; Gupta I; Dhawan V
    Int J Gynaecol Obstet; 2005 Jun; 89(3):282-3. PubMed ID: 15869757
    [No Abstract]   [Full Text] [Related]  

  • 15. Hysterographic study of some side effects of the copper T 200 device.
    Hefnawi FI; Hamed AF; Askalani H; Younis N; El Sheikha Z; Sherif H
    Popul Sci; 1982; (3):73-91. PubMed ID: 12266220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforation of uterus by the GyneFix intrauterine contraceptive device.
    al-Kamil RK
    Int J Clin Pract; 2000 Mar; 54(2):128-9. PubMed ID: 10824371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of copper intrauterine contraceptive device on the estrogen & progesterone uptake in ovariectomized rat uterus.
    Ghosh M; Roy SK
    Indian J Exp Biol; 1977 Jun; 15(6):477-8. PubMed ID: 598881
    [No Abstract]   [Full Text] [Related]  

  • 19. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
    Neale R; Knight I; Keane F
    Int J STD AIDS; 2009 Jun; 20(6):423-4. PubMed ID: 19451330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A.
    Godfrey EM; Memmel LM; Neustadt A; Shah M; Nicosia A; Moorthie M; Gilliam M
    Contraception; 2010 Feb; 81(2):123-7. PubMed ID: 20103449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.